How long does it take to work?
Stribild works quickly to drop levels of HIV-1 in the blood; however, it may take several months of treatment for viral loads to become undetectable. Stribild is an effective treatment for HIV and generally, studies have shown that during the first two months of antiviral therapy an HIV-positive person’s viral load should drop a minimum of 90 percent. Within four to 6 months, levels of the virus should have dropped further. Specific studies investigating the effectiveness of Stribild have been a minimum of 48 weeks duration. These have shown that after 48 weeks of treatment with Stribild, 94% of people have achieved virologic success, which is defined in these studies as an HIV-1 RNA of <50 copies/mL.
Stribild is a combination tablet containing elvitegravir, emtricitabine, tenofovir disoproxil fumarate (TDF), and cobicistat, which may be given as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients aged 12 years of age and older weighing at least 35 kg. Elvitegravir is an integrase inhibitor; emtricitabine and tenofovir are nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) and cobicistat boosts the activity of elvitegravir. The three antivirals (elvitegravir, emtricitabine, and tenofovir) work together to suppress the HIV-1 virus.
Stribild is taken as a single tablet once a day with food.
Related medical questions
- Does Stribild cause weight gain?
- Can Stribild be crushed?
- What medicines should not be taken with Stribild?
- How long does it take to work?
- Is Stribild used for PrEP?
- Who makes or manufactures Stribild?
- Does Stribild cause weight gain?
- Can Stribild be crushed?
- What medicines should not be taken with Stribild?
- How long does it take to work?
- Is Stribild used for PrEP?
- Who makes or manufactures Stribild?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions